These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8941074)

  • 1. A unique case of massive ascites before ovulation associated with gonadotropin therapy.
    Akman MA; Garcia JE; Katz E
    Fertil Steril; 1996 Dec; 66(6):1026-7. PubMed ID: 8941074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does metformin affect the ovarian response to gonadotropins for in vitro fertilization treatment in patients with polycystic ovary syndrome and reduced ovarian reserve? A randomized controlled trial.
    Palomba S; Falbo A; Di Cello A; Cappiello F; Tolino A; Zullo F
    Fertil Steril; 2011 Nov; 96(5):1128-33. PubMed ID: 21917254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimal ovarian hyperstimulation for in vitro fertilization using sequential clomiphene citrate and gonadotropin with or without the addition of a gonadotropin-releasing hormone antagonist.
    Williams SC; Gibbons WE; Muasher SJ; Oehninger S
    Fertil Steril; 2002 Nov; 78(5):1068-72. PubMed ID: 12413995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The outcome of in vitro fertilization and embryo transfer in women with polycystic ovary syndrome failing to conceive after ovulation induction with exogenous gonadotropins.
    Urman B; Fluker MR; Yuen BH; Fleige-Zahradka BG; Zouves CG; Moon YS
    Fertil Steril; 1992 Jun; 57(6):1269-73. PubMed ID: 1601149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous bilateral ovarian torsion in the follicular phase after gonadotropin stimulation.
    Kang HJ; Davis OK; Rosenwaks Z
    Fertil Steril; 2006 Aug; 86(2):462.e13-4. PubMed ID: 16806209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal stimulation IVF using clomiphene citrate and oral contraceptive pill pretreatment for LH suppression.
    Branigan EF; Estes MA
    Fertil Steril; 2000 Mar; 73(3):587-90. PubMed ID: 10689017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
    Jiang S; Kuang Y
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do poor-responder patients benefit from increasing the daily gonadotropin dose during controlled ovarian hyperstimulation for IVF?
    Haas J; Zilberberg E; Machtinger R; Kedem A; Hourvitz A; Orvieto R
    Gynecol Endocrinol; 2015 Jan; 31(1):79-82. PubMed ID: 25223892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of antagonist mild and long agonist protocols in terms of follicular fluid total antioxidant capacity.
    Aydogan Mathyk B; Aslan Cetin B; Vardagli D; Zengin E; Sofiyeva N; Irez T; Ocal P
    Taiwan J Obstet Gynecol; 2018 Apr; 57(2):194-199. PubMed ID: 29673660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of ovarian responsiveness with microdoses of gonadotropin-releasing hormone agonist during ovulation induction for in vitro fertilization.
    Scott RT; Navot D
    Fertil Steril; 1994 May; 61(5):880-5. PubMed ID: 8174725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mesothelial cyst of the round ligament presenting as an inguinal hernia after gonadotropin stimulation for in vitro fertilization.
    Ryley DA; Moorman DW; Hecht JL; Alper MM
    Fertil Steril; 2004 Oct; 82(4):944-6. PubMed ID: 15482776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
    Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
    Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Do poor-responder patients benefit from increasing the daily gonadotropin dose from 300 to 450 IU during controlled ovarian hyperstimulation for IVF?].
    Haas J; Zilberberg E; Kedem A; Dar S; Orvieto R
    Harefuah; 2015 Feb; 154(2):114-7, 135. PubMed ID: 25856865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gonadotropins--their side effects].
    Tojo S; Nakano R; Washio M
    Horumon To Rinsho; 1972 Oct; 20(10):787-95. PubMed ID: 4568942
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparison of the efficiency between in-vitro maturation and in-vitro fertilization after early follicular phase GnRH agonist down-regulation in infertile women with polycystic ovary syndrome].
    Zhu RR; Xiao SQ; Zhao JZ; Lin J; Wang PY; Jin CC; Jin WM
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):833-7. PubMed ID: 24444560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian response to gonadotropins in patients with tubal factor infertility: salpingectomy versus nonsalpingectomy.
    Lin YJ; Ou YC; Huang FJ; Lin PY; Kung FT; Lan KC
    J Minim Invasive Gynecol; 2013; 20(5):637-41. PubMed ID: 23706676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes.
    Weitzman VN; Engmann L; DiLuigi A; Maier D; Nulsen J; Benadiva C
    Fertil Steril; 2009 Jul; 92(1):226-30. PubMed ID: 18675961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of various gonadotropin and biosimilar formulations for in vitro fertilization cycles: results of a worldwide Web-based survey.
    Christianson MS; Shoham G; Tobler KJ; Zhao Y; Monseur B; Leong M; Shoham Z
    J Assist Reprod Genet; 2017 Aug; 34(8):1059-1066. PubMed ID: 28573524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum but not follicular fluid cytokine levels are increased in stimulated versus natural cycle IVF: a multiplexed assay study.
    Bersinger NA; Kollmann Z; Von Wolff M
    J Reprod Immunol; 2014 Dec; 106():27-33. PubMed ID: 25103590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gonadotropin-releasing hormone antagonist use is associated with increased pregnancy rates in ovulation induction-intrauterine insemination to in vitro fertilization conversions, independent of age and estradiol level on the day of human chorionic gonadotropin administration.
    Quaas AM; Missmer SA; Ginsburg ES
    Fertil Steril; 2010 Feb; 93(2):605-8. PubMed ID: 19324340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.